Ads

 

Ads

 

Ads

 

Iovance Biotherapeutics

Iovance Biotherapeutics

World Rank (Aug-2026)
4887
Market Cap (Aug-2026)
3.162 Billion USD
Market Cap (Mar-08-2026)
2.113 Billion USD
World Rank (Jan-05-2024)
5,548
Market Cap (Jan-05-2024)
2.075 Billion USD
World Rank (Jul-30-2023)
6,175
Market Cap (Jul-30-2023)
1.782 Billion USD
World Rank (Jan-07-2022)
5,413
Market Cap (Jan-07-2022)
2.554 Billion USD
World Rank (Jan-01-2021)
2,303
Market Cap (Jan-01-2021)
6.806 Billion USD
Headquarters Country
Nasdaq / NYSE Code
IOVA
Employee Count
319
Employee Count as of Date
As on 2021
Headquarters City/State
World Region
World Subregion
Annual Revenue in USD
264 Million USD
Annual Operating Income in USD
-403 Million USD
Annual Net Income in USD
-391 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
913 Million USD
Total Liabilities in USD
215 Million USD
Total Equity in USD
699 Million USD
Balance Sheet for Period Ending
As of December-2025

Share

Ads